These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29410540)

  • 21. Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility.
    Weng YH; Chiu YW
    Chang Gung Med J; 2009; 32(4):400-8. PubMed ID: 19664346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective Surveillance of Extreme Neonatal Hyperbilirubinemia in Australia.
    McGillivray A; Polverino J; Badawi N; Evans N
    J Pediatr; 2016 Jan; 168():82-87.e3. PubMed ID: 26477873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Hyperbilirubinemia in Neonates with Down Syndrome.
    Bahr TM; Henry E; Hulse W; Baer VL; Prchal JT; Bhutani VK; Christensen RD
    J Pediatr; 2020 Apr; 219():140-145. PubMed ID: 32014279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extreme neonatal hyperbilirubinemia and kernicterus spectrum disorder in Denmark during the years 2000-2015.
    Donneborg ML; Hansen BM; Vandborg PK; Rodrigo-Domingo M; Ebbesen F
    J Perinatol; 2020 Feb; 40(2):194-202. PubMed ID: 31907395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers.
    Talwar M; Jain A; Sharma RR; Kumar P; Saha SC; Singh L
    Vox Sang; 2022 Sep; 117(9):1112-1120. PubMed ID: 35667836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Cord Blood Carboxyhemoglobin in Detecting Significant Hyperbilirubinemia in Term Neonates with ABO Alloimmunization.
    Tıraş M; Can E; Hamilçıkan Ş
    Am J Perinatol; 2022 Sep; 39(12):1321-1325. PubMed ID: 33395710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial difference in incidence of ABO hemolytic disease.
    Bucher KA; Patterson AM; Elston RC; Jones CA; Kirkman HN
    Am J Public Health; 1976 Sep; 66(9):854-8. PubMed ID: 961953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of Gilbert's Syndrome-Associated UGT1A1 Polymorphism in Jaundiced Neonates of ABO Incompatibility Hemolysis Disease.
    Yu Y; Du L; Chen A; Chen L
    Am J Perinatol; 2020 May; 37(6):652-658. PubMed ID: 31087315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-test probability for neonatal hyperbilirubinemia based on umbilical cord blood bilirubin, direct antiglobulin test, and ABO compatibility results.
    Peeters B; Geerts I; Van Mullem M; Micalessi I; Saegeman V; Moerman J
    Eur J Pediatr; 2016 May; 175(5):651-7. PubMed ID: 26782094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and causes of severe neonatal hyperbilirubinemia in Canada.
    Sgro M; Campbell D; Shah V
    CMAJ; 2006 Sep; 175(6):587-90. PubMed ID: 16966660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morbidity of ABO haemolytic disease in the newborn.
    Bhat YR; Kumar CG
    Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights.
    Watchko JF
    Pediatr Clin North Am; 2009 Jun; 56(3):671-87, Table of Contents. PubMed ID: 19501698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indication of Mild Hemolytic Reaction Among Preterm Infants With ABO Incompatibility.
    Yogev-Lifshitz M; Leibovitch L; Schushan-Eisen I; Taran C; Strauss T; Maayan-Metzger A
    Pediatr Blood Cancer; 2016 Jun; 63(6):1050-3. PubMed ID: 26841084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.
    Kaplan M; Na'amad M; Kenan A; Rudensky B; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
    Pediatrics; 2009 Jan; 123(1):e132-7. PubMed ID: 19114458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Gilbert syndrome in parents of neonates with pathologic indirect hyperbilirubinemia.
    Saki F; Hemmati F; Haghighat M
    Ann Saudi Med; 2011; 31(2):140-4. PubMed ID: 21403409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sixth hour transcutaneous bilirubin predicting significant hyperbilirubinemia in ABO incompatible neonates.
    Bhat RY; Kumar PC
    World J Pediatr; 2014 May; 10(2):182-5. PubMed ID: 23775679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of screening for bilirubin encephalopathy in neonates.
    Trikalinos TA; Chung M; Lau J; Ip S
    Pediatrics; 2009 Oct; 124(4):1162-71. PubMed ID: 19786450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The Correlation Analysis between the Titer of IgG Anti-A/B Erythrocyte Antibody In Vivo of the Neonate and the Severity of Hemolytic Disease of Newborn].
    Song J; Yang T; Zhou XF; Yang YZ; Peng DL; Zhang JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):547-551. PubMed ID: 35395995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Roles of UGT 1A1 gene mutation in the development of neonatal hyperbilirubinemia in Guangxi].
    Gao ZY; Zhong DN; Liu Y; Liu YN; Wei LM
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):646-9. PubMed ID: 21092520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother.
    Drabik-Clary K; Reddy VV; Benjamin WH; Boctor FN
    Ann Clin Lab Sci; 2006; 36(2):205-7. PubMed ID: 16682519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.